论文部分内容阅读
为了解选择性支气管动脉灌注化疗（BAI）近期疗效的影响因素，对69例中晚期肺癌行BAI治疗，按病变部位、大小、组织类型、肿瘤血管构型、血供类型及操作技术等分类分析，评价疗效。结果：①直径≤5cm，中央型，小细胞未分化癌及鳞癌，多血管构型，少血供者与直径＞5cm，周围型，腺癌，少血管构型，多血供类型患者之间的疗效差异有显著性，前者优于后者（P＜0．05）；②操作技术是影响BAI近期疗效的重要因素之一。结论：①BAI治疗应尽量选灌，减少盲灌；②鳞癌首选BAI治疗，小细胞未分化癌以全身化疗为基础，辅助应用BAI治疗；腺癌可先行BAI，几次BAI治疗中间或之后，配合全身化疗，治疗或预防远处转移。
In order to understand the influencing factors of selective bronchial arterial infusion chemotherapy (BAI), BAI treatment was performed on 69 patients with advanced lung cancer according to the classification of lesion location, size, tissue type, tumor vascular configuration, blood supply type and operation technique. , Evaluate the efficacy. RESULTS: 1 Diameter ≤ 5cm, central type, small cell undifferentiated carcinoma and squamous cell carcinoma, multiple vessel configuration, less blood donors and diameter> 5cm, peripheral type, adenocarcinoma, less vessel configuration, patients with multiple blood supply types The difference in efficacy between the two groups was significant. The former was superior to the latter (P<0.05). 2 Operational techniques were one of the important factors affecting the short-term efficacy of BAI. Conclusion: 1BAI treatment should try to select irrigation and reduce blind irrigation. 2The squamous cell carcinoma is the first choice for BAI treatment. The small cell undifferentiated carcinoma is based on systemic chemotherapy and is assisted by BAI; adenocarcinoma can be first performed by BAI, and several times by BAI treatment. With systemic chemotherapy, treatment or prevention of distant metastasis.